[6-[6-(2,4-dimethylpentan-3-ylamino)-5-methylpyridazin-3-yl]-3-(4-methylimidazol-1-yl)-2-pyridinyl]methanol;2-ethyl-1-[[6-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]pyridazin-3-yl]methyl]-4,5,6,7-tetrahydroisoindole;6-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-4-methyl-3-[(2R)-2-(5-methyl-2-pyridinyl)butyl]pyridazine;[3-(4-methylimidazol-1-yl)-6-[5-methyl-6-(pentan-3-ylamino)pyridazin-3-yl]-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[5-methyl-6-[[4-(trifluoromethyl)cyclohexyl]amino]pyridazin-3-yl]-2-pyridinyl]methanol

C114H137F3N30O5 — CID 159126136

IUPAC[6-[6-(2,4-dimethylpentan-3-ylamino)-5-methylpyridazin-3-yl]-3-(4-methylimidazol-1-yl)-2-pyridinyl]methanol;2-ethyl-1-[[6-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]pyridazin-3-yl]methyl]-4,5,6,7-tetrahydroisoindole;6-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-4-methyl-3-[(2R)-2-(5-methyl-2-pyridinyl)butyl]pyridazine;[3-(4-methylimidazol-1-yl)-6-[5-methyl-6-(pentan-3-ylamino)pyridazin-3-yl]-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[5-methyl-6-[[4-(trifluoromethyl)cyclohexyl]amino]pyridazin-3-yl]-2-pyridinyl]methanol
SMILESCCC(CC)Nc1nnc(-c2ccc(-n3cnc(C)c3)c(CO)n2)cc1C.CC[C@H](Cc1nnc(-c2ccc(-n3cnc(C)c3)c(OC)n2)cc1C)c1ccc(C)cn1.CCn1cc2c(c1Cc1ccc(-c3ccc(-n4cnc(C)c4)c(OC)n3)nn1)CCCC2.Cc1cn(-c2ccc(-c3cc(C)c(NC(C(C)C)C(C)C)nn3)nc2CO)cn1.Cc1cn(-c2ccc(-c3cc(C)c(NC4CCC(C(F)(F)F)CC4)nn3)nc2CO)cn1
InChIInChI=1S/2C25H28N6O.C22H25F3N6O.C22H30N6O.C20H26N6O/c1-4-30-15-18-7-5-6-8-20(18)24(30)13-19-9-10-22(29-28-19)21-11-12-23(25(27-21)32-3)31-14-17(2)26-16-31;1-6-19(20-8-7-16(2)13-26-20)12-22-17(3)11-23(30-29-22)21-9-10-24(25(28-21)32-5)31-14-18(4)27-15-31;1-13-9-18(17-7-8-20(19(11-32)28-17)31-10-14(2)26-12-31)29-30-21(13)27-16-5-3-15(4-6-16)22(23,24)25;1-13(2)21(14(3)4)25-22-15(5)9-18(26-27-22)17-7-8-20(19(11-29)24-17)28-10-16(6)23-12-28;1-5-15(6-2)22-20-13(3)9-17(24-25-20)16-7-8-19(18(11-27)23-16)26-10-14(4)21-12-26/h9-12,14-16H,4-8,13H2,1-3H3;7-11,13-15,19H,6,12H2,1-5H3;7-10,12,15-16,32H,3-6,11H2,1-2H3,(H,27,30);7-10,12-14,21,29H,11H2,1-6H3,(H,25,27);7-10,12,15,27H,5-6,11H2,1-4H3,(H,22,25)/t;19-;;;/m.1.../s1
InChIKeyKGHKIXIVIBVZSV-HHZPVKHOSA-N
MW2064.55 g/mol
LogP20.85
Rot. Bonds32

About [6-[6-(2,4-dimethylpentan-3-ylamino)-5-methylpyridazin-3-yl]-3-(4-methylimidazol-1-yl)-2-pyridinyl]methanol;2-ethyl-1-[[6-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]pyridazin-3-yl]methyl]-4,5,6,7-tetrahydroisoindole;6-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-4-methyl-3-[(2R)-2-(5-methyl-2-pyridinyl)butyl]pyridazine;[3-(4-methylimidazol-1-yl)-6-[5-methyl-6-(pentan-3-ylamino)pyridazin-3-yl]-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[5-methyl-6-[[4-(trifluoromethyl)cyclohexyl]amino]pyridazin-3-yl]-2-pyridinyl]methanol

[6-[6-(2,4-dimethylpentan-3-ylamino)-5-methylpyridazin-3-yl]-3-(4-methylimidazol-1-yl)-2-pyridinyl]methanol;2-ethyl-1-[[6-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]pyridazin-3-yl]methyl]-4,5,6,7-tetrahydroisoindole;6-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-4-methyl-3-[(2R)-2-(5-methyl-2-pyridinyl)butyl]pyridazine;[3-(4-methylimidazol-1-yl)-6-[5-methyl-6-(pentan-3-ylamino)pyridazin-3-yl]-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[5-methyl-6-[[4-(trifluoromethyl)cyclohexyl]amino]pyridazin-3-yl]-2-pyridinyl]methanol (PubChem CID 159126136) has the molecular formula C114H137F3N30O5 and a molecular weight of 2064.55 g/mol. Its IUPAC name is [6-[6-(2,4-dimethylpentan-3-ylamino)-5-methylpyridazin-3-yl]-3-(4-methylimidazol-1-yl)-2-pyridinyl]methanol;2-ethyl-1-[[6-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]pyridazin-3-yl]methyl]-4,5,6,7-tetrahydroisoindole;6-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-4-methyl-3-[(2R)-2-(5-methyl-2-pyridinyl)butyl]pyridazine;[3-(4-methylimidazol-1-yl)-6-[5-methyl-6-(pentan-3-ylamino)pyridazin-3-yl]-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[5-methyl-6-[[4-(trifluoromethyl)cyclohexyl]amino]pyridazin-3-yl]-2-pyridinyl]methanol.

Molecular Properties

Compound Name[6-[6-(2,4-dimethylpentan-3-ylamino)-5-methylpyridazin-3-yl]-3-(4-methylimidazol-1-yl)-2-pyridinyl]methanol;2-ethyl-1-[[6-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]pyridazin-3-yl]methyl]-4,5,6,7-tetrahydroisoindole;6-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-4-methyl-3-[(2R)-2-(5-methyl-2-pyridinyl)butyl]pyridazine;[3-(4-methylimidazol-1-yl)-6-[5-methyl-6-(pentan-3-ylamino)pyridazin-3-yl]-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[5-methyl-6-[[4-(trifluoromethyl)cyclohexyl]amino]pyridazin-3-yl]-2-pyridinyl]methanol
PubChem CID159126136
Molecular FormulaC114H137F3N30O5
Molecular Weight2064.55 g/mol
Exact Mass2063.13
IUPAC Name[6-[6-(2,4-dimethylpentan-3-ylamino)-5-methylpyridazin-3-yl]-3-(4-methylimidazol-1-yl)-2-pyridinyl]methanol;2-ethyl-1-[[6-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]pyridazin-3-yl]methyl]-4,5,6,7-tetrahydroisoindole;6-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-4-methyl-3-[(2R)-2-(5-methyl-2-pyridinyl)butyl]pyridazine;[3-(4-methylimidazol-1-yl)-6-[5-methyl-6-(pentan-3-ylamino)pyridazin-3-yl]-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[5-methyl-6-[[4-(trifluoromethyl)cyclohexyl]amino]pyridazin-3-yl]-2-pyridinyl]methanol
SMILESCCC(CC)Nc1nnc(-c2ccc(-n3cnc(C)c3)c(CO)n2)cc1C.CC[C@H](Cc1nnc(-c2ccc(-n3cnc(C)c3)c(OC)n2)cc1C)c1ccc(C)cn1.CCn1cc2c(c1Cc1ccc(-c3ccc(-n4cnc(C)c4)c(OC)n3)nn1)CCCC2.Cc1cn(-c2ccc(-c3cc(C)c(NC(C(C)C)C(C)C)nn3)nc2CO)cn1.Cc1cn(-c2ccc(-c3cc(C)c(NC4CCC(C(F)(F)F)CC4)nn3)nc2CO)cn1
InChIInChI=1S/2C25H28N6O.C22H25F3N6O.C22H30N6O.C20H26N6O/c1-4-30-15-18-7-5-6-8-20(18)24(30)13-19-9-10-22(29-28-19)21-11-12-23(25(27-21)32-3)31-14-17(2)26-16-31;1-6-19(20-8-7-16(2)13-26-20)12-22-17(3)11-23(30-29-22)21-9-10-24(25(28-21)32-5)31-14-18(4)27-15-31;1-13-9-18(17-7-8-20(19(11-32)28-17)31-10-14(2)26-12-31)29-30-21(13)27-16-5-3-15(4-6-16)22(23,24)25;1-13(2)21(14(3)4)25-22-15(5)9-18(26-27-22)17-7-8-20(19(11-29)24-17)28-10-16(6)23-12-28;1-5-15(6-2)22-20-13(3)9-17(24-25-20)16-7-8-19(18(11-27)23-16)26-10-14(4)21-12-26/h9-12,14-16H,4-8,13H2,1-3H3;7-11,13-15,19H,6,12H2,1-5H3;7-10,12,15-16,32H,3-6,11H2,1-2H3,(H,27,30);7-10,12-14,21,29H,11H2,1-6H3,(H,25,27);7-10,12,15,27H,5-6,11H2,1-4H3,(H,22,25)/t;19-;;;/m.1.../s1
InChIKeyKGHKIXIVIBVZSV-HHZPVKHOSA-N
XLogP20.85
TPSA415.51 Ų
H-Bond Donors6
H-Bond Acceptors35
Rotatable Bonds32
Heavy Atoms152
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002064.55
LogP ≤ 520.85
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1035

Analyze [6-[6-(2,4-dimethylpentan-3-ylamino)-5-methylpyridazin-3-yl]-3-(4-methylimidazol-1-yl)-2-pyridinyl]methanol;2-ethyl-1-[[6-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]pyridazin-3-yl]methyl]-4,5,6,7-tetrahydroisoindole;6-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-4-methyl-3-[(2R)-2-(5-methyl-2-pyridinyl)butyl]pyridazine;[3-(4-methylimidazol-1-yl)-6-[5-methyl-6-(pentan-3-ylamino)pyridazin-3-yl]-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[5-methyl-6-[[4-(trifluoromethyl)cyclohexyl]amino]pyridazin-3-yl]-2-pyridinyl]methanol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [6-[6-(2,4-dimethylpentan-3-ylamino)-5-methylpyridazin-3-yl]-3-(4-methylimidazol-1-yl)-2-pyridinyl]methanol;2-ethyl-1-[[6-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]pyridazin-3-yl]methyl]-4,5,6,7-tetrahydroisoindole;6-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-4-methyl-3-[(2R)-2-(5-methyl-2-pyridinyl)butyl]pyridazine;[3-(4-methylimidazol-1-yl)-6-[5-methyl-6-(pentan-3-ylamino)pyridazin-3-yl]-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[5-methyl-6-[[4-(trifluoromethyl)cyclohexyl]amino]pyridazin-3-yl]-2-pyridinyl]methanol?
The IUPAC name of [6-[6-(2,4-dimethylpentan-3-ylamino)-5-methylpyridazin-3-yl]-3-(4-methylimidazol-1-yl)-2-pyridinyl]methanol;2-ethyl-1-[[6-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]pyridazin-3-yl]methyl]-4,5,6,7-tetrahydroisoindole;6-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-4-methyl-3-[(2R)-2-(5-methyl-2-pyridinyl)butyl]pyridazine;[3-(4-methylimidazol-1-yl)-6-[5-methyl-6-(pentan-3-ylamino)pyridazin-3-yl]-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[5-methyl-6-[[4-(trifluoromethyl)cyclohexyl]amino]pyridazin-3-yl]-2-pyridinyl]methanol (CID 159126136) is [6-[6-(2,4-dimethylpentan-3-ylamino)-5-methylpyridazin-3-yl]-3-(4-methylimidazol-1-yl)-2-pyridinyl]methanol;2-ethyl-1-[[6-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]pyridazin-3-yl]methyl]-4,5,6,7-tetrahydroisoindole;6-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-4-methyl-3-[(2R)-2-(5-methyl-2-pyridinyl)butyl]pyridazine;[3-(4-methylimidazol-1-yl)-6-[5-methyl-6-(pentan-3-ylamino)pyridazin-3-yl]-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[5-methyl-6-[[4-(trifluoromethyl)cyclohexyl]amino]pyridazin-3-yl]-2-pyridinyl]methanol.
What is the SMILES notation for [6-[6-(2,4-dimethylpentan-3-ylamino)-5-methylpyridazin-3-yl]-3-(4-methylimidazol-1-yl)-2-pyridinyl]methanol;2-ethyl-1-[[6-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]pyridazin-3-yl]methyl]-4,5,6,7-tetrahydroisoindole;6-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-4-methyl-3-[(2R)-2-(5-methyl-2-pyridinyl)butyl]pyridazine;[3-(4-methylimidazol-1-yl)-6-[5-methyl-6-(pentan-3-ylamino)pyridazin-3-yl]-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[5-methyl-6-[[4-(trifluoromethyl)cyclohexyl]amino]pyridazin-3-yl]-2-pyridinyl]methanol?
The canonical SMILES for [6-[6-(2,4-dimethylpentan-3-ylamino)-5-methylpyridazin-3-yl]-3-(4-methylimidazol-1-yl)-2-pyridinyl]methanol;2-ethyl-1-[[6-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]pyridazin-3-yl]methyl]-4,5,6,7-tetrahydroisoindole;6-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-4-methyl-3-[(2R)-2-(5-methyl-2-pyridinyl)butyl]pyridazine;[3-(4-methylimidazol-1-yl)-6-[5-methyl-6-(pentan-3-ylamino)pyridazin-3-yl]-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[5-methyl-6-[[4-(trifluoromethyl)cyclohexyl]amino]pyridazin-3-yl]-2-pyridinyl]methanol is CCC(CC)Nc1nnc(-c2ccc(-n3cnc(C)c3)c(CO)n2)cc1C.CC[C@H](Cc1nnc(-c2ccc(-n3cnc(C)c3)c(OC)n2)cc1C)c1ccc(C)cn1.CCn1cc2c(c1Cc1ccc(-c3ccc(-n4cnc(C)c4)c(OC)n3)nn1)CCCC2.Cc1cn(-c2ccc(-c3cc(C)c(NC(C(C)C)C(C)C)nn3)nc2CO)cn1.Cc1cn(-c2ccc(-c3cc(C)c(NC4CCC(C(F)(F)F)CC4)nn3)nc2CO)cn1.
What is the InChIKey of [6-[6-(2,4-dimethylpentan-3-ylamino)-5-methylpyridazin-3-yl]-3-(4-methylimidazol-1-yl)-2-pyridinyl]methanol;2-ethyl-1-[[6-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]pyridazin-3-yl]methyl]-4,5,6,7-tetrahydroisoindole;6-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-4-methyl-3-[(2R)-2-(5-methyl-2-pyridinyl)butyl]pyridazine;[3-(4-methylimidazol-1-yl)-6-[5-methyl-6-(pentan-3-ylamino)pyridazin-3-yl]-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[5-methyl-6-[[4-(trifluoromethyl)cyclohexyl]amino]pyridazin-3-yl]-2-pyridinyl]methanol?
The InChIKey is KGHKIXIVIBVZSV-HHZPVKHOSA-N. The full InChI is InChI=1S/2C25H28N6O.C22H25F3N6O.C22H30N6O.C20H26N6O/c1-4-30-15-18-7-5-6-8-20(18)24(30)13-19-9-10-22(29-28-19)21-11-12-23(25(27-21)32-3)31-14-17(2)26-16-31;1-6-19(20-8-7-16(2)13-26-20)12-22-17(3)11-23(30-29-22)21-9-10-24(25(28-21)32-5)31-14-18(4)27-15-31;1-13-9-18(17-7-8-20(19(11-32)28-17)31-10-14(2)26-12-31)29-30-21(13)27-16-5-3-15(4-6-16)22(23,24)25;1-13(2)21(14(3)4)25-22-15(5)9-18(26-27-22)17-7-8-20(19(11-29)24-17)28-10-16(6)23-12-28;1-5-15(6-2)22-20-13(3)9-17(24-25-20)16-7-8-19(18(11-27)23-16)26-10-14(4)21-12-26/h9-12,14-16H,4-8,13H2,1-3H3;7-11,13-15,19H,6,12H2,1-5H3;7-10,12,15-16,32H,3-6,11H2,1-2H3,(H,27,30);7-10,12-14,21,29H,11H2,1-6H3,(H,25,27);7-10,12,15,27H,5-6,11H2,1-4H3,(H,22,25)/t;19-;;;/m.1.../s1.
What are the key properties of [6-[6-(2,4-dimethylpentan-3-ylamino)-5-methylpyridazin-3-yl]-3-(4-methylimidazol-1-yl)-2-pyridinyl]methanol;2-ethyl-1-[[6-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]pyridazin-3-yl]methyl]-4,5,6,7-tetrahydroisoindole;6-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-4-methyl-3-[(2R)-2-(5-methyl-2-pyridinyl)butyl]pyridazine;[3-(4-methylimidazol-1-yl)-6-[5-methyl-6-(pentan-3-ylamino)pyridazin-3-yl]-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[5-methyl-6-[[4-(trifluoromethyl)cyclohexyl]amino]pyridazin-3-yl]-2-pyridinyl]methanol?
[6-[6-(2,4-dimethylpentan-3-ylamino)-5-methylpyridazin-3-yl]-3-(4-methylimidazol-1-yl)-2-pyridinyl]methanol;2-ethyl-1-[[6-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]pyridazin-3-yl]methyl]-4,5,6,7-tetrahydroisoindole;6-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-4-methyl-3-[(2R)-2-(5-methyl-2-pyridinyl)butyl]pyridazine;[3-(4-methylimidazol-1-yl)-6-[5-methyl-6-(pentan-3-ylamino)pyridazin-3-yl]-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[5-methyl-6-[[4-(trifluoromethyl)cyclohexyl]amino]pyridazin-3-yl]-2-pyridinyl]methanol has a molecular weight of 2064.55 g/mol, XLogP of 20.85, 32 rotatable bonds, 6 hydrogen bond donors, and 35 hydrogen bond acceptors.
Where does this data come from?
All data for [6-[6-(2,4-dimethylpentan-3-ylamino)-5-methylpyridazin-3-yl]-3-(4-methylimidazol-1-yl)-2-pyridinyl]methanol;2-ethyl-1-[[6-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]pyridazin-3-yl]methyl]-4,5,6,7-tetrahydroisoindole;6-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-4-methyl-3-[(2R)-2-(5-methyl-2-pyridinyl)butyl]pyridazine;[3-(4-methylimidazol-1-yl)-6-[5-methyl-6-(pentan-3-ylamino)pyridazin-3-yl]-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[5-methyl-6-[[4-(trifluoromethyl)cyclohexyl]amino]pyridazin-3-yl]-2-pyridinyl]methanol is sourced from PubChem (CID 159126136), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).